Rosette Lidereau

27.1k citations
265 papers · 16.7k · 2 hit papers · h-index 70

Impact in

    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies
  • Oncology top 0.2%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • Genomics and Chromatin Dynamics 24
    • Cancer-related Molecular Pathways 42
    • HER2/EGFR in Cancer Research 22

Rosette Lidereau

262 papers receiving 16.2k citations

Rosette Lidereau's Hit Papers

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series 2007 · 759 citations
7590+6+13Years since publication250500750

Peers

Rosette Lidereau
Comparison fields: 5 of 148
  • Cancer Research 4.4k
  • Oncology 5.6k
  • Molecular Biology 8.5k
  • Genetics 3.1k
  • Pathology and Forensic Medicine 1.8k
Replace Åke Borg with:
Åke Borg Sweden
Ann D. Thor United States
Elizabeth A. Musgrove Australia
Robert L. Sutherland Australia
Ivan Bièche France
Shirley Zhu United States
Michael J. Birrer United States
Jennifer A. Pietenpol United States
Celina G. Kleer United States
Anne‐Lise Børresen‐Dale Norway
Rosette Lidereau relative to Åke Borg Sweden Åke Borg's profile →
Citations per field
00.5×1.5×
Åke Borg · 1×
Citations per year

Countries citing papers authored by Rosette Lidereau

Since Specialization
Citations

This map shows the geographic impact of Rosette Lidereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosette Lidereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosette Lidereau more than expected).

Fields of papers citing papers by Rosette Lidereau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosette Lidereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosette Lidereau. The network helps show where Rosette Lidereau may publish in the future.

Co-authors

The 25 scholars most cited alongside Rosette Lidereau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rosette Lidereau Line = papers co-authored together Rosette Lidereau links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 265 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
Hit paper breakdown →
2006916
2
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
Hit paper breakdown →
2007759
3 2007473
4 2006456
5 1986365
6 1987301
7
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
2003298
8 2007291
9 1995270
10 1995226
11 1999223
12 2011223
13
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
2001212
14
Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.
1999211
15 1988210
16 1998206
17 1994202
18
Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
1986200
19 2006197
20 2004194

About Rosette Lidereau

Rosette Lidereau is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 265 papers that have together received 16.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (42 papers), Cancer Genomics and Diagnostics (35 papers), BRCA gene mutations in cancer (28 papers), Genetic factors in colorectal cancer (25 papers), Genomics and Chromatin Dynamics (24 papers), HER2/EGFR in Cancer Research (22 papers), Genomic variations and chromosomal abnormalities (22 papers) and Estrogen and related hormone effects (19 papers). The work is most often cited by research in Cancer Research (4.4k citations), Oncology (5.6k citations), Molecular Biology (8.5k citations), Genetics (3.1k citations) and Pathology and Forensic Medicine (1.8k citations). Rosette Lidereau has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Ivan Bièche, Robert Callahan, Michel Vidaud, Sengül Tozlu, Sophie Vacher, Keltouma Driouch, Charles Theillet, Igor Girault, M.H. Champème and Imran Ali. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Genes Chromosomes and Cancer, Oncogene and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact